12:08 PM EST - Cipher Pharmaceuticals Inc. : Has appointed seasoned Financial Executive Scott Langille as its new Chief Financial Officer (CFO), he will succeed Interim CFO Nadine Jutlah.Langille brings with him an extensive background in corporate and operational finance with strong experience in both branded and generic pharmaceuticals, medical devices and biotechnology. Langille has held senior roles at Tribute Pharmaceuticals, ViRexx Medical Corp, Zimmer Holdings, Verum Pharmaceuticals and Biovail Corporation. Cipher Pharmaceuticals Inc.
shares T.CPH are trading down $0.02 at $1.18.
